Efficacy of low-dose intravenous cyclophosphamide in systemic lupus erythematosus presenting with Guillain-Barré syndrome-like acute axonal neuropathies: Report of two cases

Lupus

Volumn 22, Issue 3, 2013, Pages 324-327

  Santiago Casas, Y ^a   Peredo, R A ^b   Vila L M ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

cyclophosphamide; Guillain Barr syndrome; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISONE;

ACUTE MOTOR AXONAL NEUROPATHY; ADULT; ARTICLE; BURNING SENSATION; CASE REPORT; DENERVATION; DIPLOPIA; DRUG PULSE THERAPY; DYSPHAGIA; ELECTRODIAGNOSIS; EXTENSOR MUSCLE; FEMALE; FLEXOR MUSCLE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HOSPITALIZATION; HUMAN; LABORATORY TEST; LYMPHOCYTOPENIA; MAINTENANCE THERAPY; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; NERVE CONDUCTION; OPHTHALMOPLEGIA; PARESTHESIA; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; REMISSION; RESPIRATORY FAILURE; SWELLING; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; CYCLOPHOSPHAMIDE; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYNEUROPATHIES; YOUNG ADULT;

EID: 84874416215     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313476358     Document Type: Article

References (21)

1. McNicholl JM, Glynn D, Mongey A, Hutchinson M, Brestnihan B. A prospective study of neurophysiologic, neurologic and immunologic abnormalities in systemic lupus erythematosus. J Rheumatol. 1994 ; 21: 1061-6
2. Levin KH. Variants and mimics of Guillain Barre syndrome. Neurologist. 2004 ; 10: 61-74
3. Chaudhuri KR, Taylor IK, Niven RM, Abbott RJ. A case of systemic lupus erythematosus presenting as Guillain-Barré syndrome. Br J Rheumatol. 1989 ; 28: 440-442
4. Robson MG, Walport MJ, Davies KA. Systemic lupus erythematosus and acute demyelinating polyneuropathy. Br J Rheumatol. 1994 ; 30: 314-316
5. Vaidya S, Jasin HE, Logan J. Systemic lupus erythematosus and Guillain-Barre syndrome. J Clin Rheumatol. 1999 ; 5: 349-53
6. van Laarhoven HWM, Rooyer Fergus A, van Engelen BGM, van Dalen R, Berden JHM. Guillain-Barré syndrome as presenting feature in a patient with lupus nephritis, with complete resolution after cyclophosphamide treatment. Nephrol Dial Transplant. 2001 ; 16: 840-842
7. Ait Benhaddou E, Birouk N, El Alaoui-Faris M, et al. Acute Guillain-Barré-like polyradiculoneuritis revealing acute systemic lupus erythematosus: Two case studies and review of the literature. Rev Neurol (Paris). 2003 ; 159: 300-306
8. Korn-Lubetzki I, Abramsky O. Acute and chronic demyelinating inflammatory polyradiculoneuropathy. Association with autoimmune diseases and lymphocyte response to human neuritogenic protein. Arch Neurol. 1986 ; 43: 604-608
9. Ho TW, Li CY, Cornblath DR, Gao CY, Asbury AK, Griffin JW, McKhann GM. Patterns of recovery in the Guillain-Barré syndromes. Neurology. 1997 ; 48: 695-700
10. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barré syndrome: An update. J Clin Neurosci. 2009 ; 16: 733-741
11. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005 ; 366: 1653-1666
12. Awad A, Mathew S, Katirji B. Acute motor axonal neuropathy in association with Sjögren syndrome. Muscle Nerve. 2010 ; 42: 828-830
13. Yildiz OK, Balaban H, Senel S, Cevik S. Acute lumbosacral polyradiculoneuropathy heralding transformation to systemic lupus erythematosus in a patient with discoid lupus. Lupus. 2011 ; 20: 972-974
14. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol. 1996 ; 39: 17-28
15. Ubogu EE, Zaidat OO, Suarez JI. Acute motor-sensory axonal neuropathy associated with active systemic lupus erythematosus and anticardiolipin antibodies. J Clin Rheumatol. 2001 ; 7: 326-331
16. Levine SR, Welch KM. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol. 1987 ; 44: 876-883
17. Hughes RA, Wijdicks EF, Barohn R, et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: Immunotherapy for Guillain-Barré syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003 ; 61: 736-740
18. Hsu TY, Wang SH, Kuo CF, Chiu TF, Chang YC. Acute inflammatory demyelinating polyneuropathy as the initial presentation of lupus. Am J Emerg Med. 2009 ; 27: 900.e3-900.e5
19. Lesprit P, Mouloud F, Bierling P, et al. Prolonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulin. Scand J Rheumatol. 1996 ; 25: 177-179
20. Aranow C, Ginzler EM Rheumatology. 4 th ed. Philadelphia: Mosby/Elsevier, 2008, pp. 1309-1318. Hochberg MC Silman AJ Smolen JS Weinblatt ME Weisman MH, ed. Philadelphia: Mosby/Elsevier ; 2008: 1309-1318.
21. Houssiau FA, Vasconcelos C, D'Cruz D, et al. Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002 ; 46: 2121-2131